Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaleon Regulatory News (HLN)

Share Price Information for Haleon (HLN)

Share Price is delayed by 15 minutes
Get Live Data
321.20    0.30 (0.09%)
Bid:
320.40
Ask:
320.50
Spread: 0.10 (0.031%)
Market Cap: £28.42b
HLN Live PriceLast checked at - London Stock Exchange

Intraday Haleon Share Chart

Director/PDMR Shareholding

10 Oct 2022 16:45

RNS Number : 3876C
Haleon PLC
10 October 2022
 

10 October 2022

 

Haleon plc

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

On 6 October 2022, Haleon made awards under the 2022 Performance Share Plan (PSP) to its Executive Directors as follows:

Role

Name

Number of Shares

Plan

Share type

Chief Executive Officer

Brian McNamara

2,049,305

PSP

ORD

Chief Financial Officer

Tobias Hestler

892,587

PSP

ORD

 

The awards are in respect of the 2022 - 2024 performance period and will vest following the announcement of the FY 2024 results. A two-year post-vesting holding period will apply to these awards.

The following PSP performance measures and target ranges were adopted for the 2022 - 2024 performance period:

Measure

Weighting

Target ranges

Threshold

(25% vesting)

Maximum

(100% vesting)

Cumulative Free Cash Flow

(Measured on a cumulative basis over the performance period FY 22, 23, 24)

50%

£4.557bn

£5.557bn

Net Debt / Adjusted EBITDA

(Measured as a ratio at year end 2024)

50%

3.0x

2.4x

In addition, when determining the level of vesting of the 2022 PSP awards, the Remuneration Committee will apply an ESG qualifier which will include the Company's performance against milestones across carbon reduction, recycle-ready packaging and diversity. If performance against those milestones is not achieved, vesting levels may be reduced. Details of performance against each of the thresholds and level of reduction applied by the Remuneration Committee, if applicable, will be fully disclosed in the 2024 Directors' Remuneration Report.

For completeness, the following Annual Incentive Plan (AIP) performance measures were adopted for the one-year period ending on 31 December 2022:

 

Organic Sales Growth (60% weighting);

Adjusted Operating Profit (20% weighting); and

Individual Business Objectives (20% weighting).

Executive Directors are required to defer 50 per cent. of any AIP earned into an award over shares which normally vest on the third anniversary of grant.

 

Full details of the performance targets for the 2022 AIP and 2022 PSP awards will be disclosed in the 2022 Directors' Remuneration Report, which will be published in H1 2023.

 

Amanda Mellor

Company Secretary

 

***

Notification and Public Disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMR") and Persons Closely Associated with them.

 

 

Details of the person discharging managerial responsibilities / person closely associated  

 

a)

 

Name

 

Brian McNamara

 

 

Reason for the notification  

 

a)

 

Position/status

 

 

Chief Executive Officer - Person Discharging Managerial Responsibilities 

b)

 

Initial notification /Amendment 

Initial Notification 

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

 

Name

 

Haleon plc 

b)

 

LEI

 

549300PSB3WWEODCUP19 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

 

Haleon plc Ordinary shares

Identification code

GB00BMX86B70

b)

 

Nature of the transaction

 

Grant of a conditional award under the Haleon plc Performance Share Plan

c)

 

Price(s) and volume(s)

Price(s) 

Volume(s) 

Nil

2,049,305

d)

 

Aggregated information

- Aggregated volume 

2,049,305

- Price 

N/A

e)

 

Date of the transaction

 

6 October 2022

f)

 

Place of the transaction

 

London Stock Exchange 

 

 

 

 

 

Details of the person discharging managerial responsibilities / person closely associated  

 

a)

 

Name

 

Tobias Hestler

 

 

Reason for the notification  

 

a)

 

Position/status

 

 

Chief Financial Officer - Person Discharging Managerial Responsibilities 

b)

 

Initial notification /Amendment

 

Initial Notification 

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

 

a)

 

Name

 

Haleon plc 

b)

 

LEI

 

549300PSB3WWEODCUP19 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

 

a)

 

Description of the financial instrument, type of instrument

 

Haleon plc Ordinary shares

Identification code

GB00BMX86B70

b)

 

Nature of the transaction

 

Grant of a conditional award under the Haleon plc Performance Share Plan

c)

 

Price(s) and volume(s)

Price(s) 

Volume(s) 

Nil

892,587

d)

 

Aggregated information

- Aggregated volume 

892,587

- Price 

N/A

e)

 

Date of the transaction

 

6 October 2022

f)

 

Place of the transaction

 

London Stock Exchange 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUBDGCDBDGDG
Date   Source Headline
3rd Apr 20235:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20235:00 pmRNSDirector/PDMR Shareholding
21st Mar 20233:00 pmRNSDirector/PDMR Shareholding
20th Mar 20233:15 pmRNSAnnual Financial Report 2022 and Notice of AGM
13th Mar 20235:00 pmRNSDirector/PDMR Shareholding
9th Mar 20233:30 pmRNSEnvironmental & Social Sustainability Committee
7th Mar 20232:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSHaleon Full Year Results 2022
13th Feb 20233:00 pmRNSDirector/PDMR Shareholding
7th Feb 202311:50 amRNSOutcome of audit tender
31st Jan 202312:06 pmRNSBoard changes
17th Jan 202311:07 amRNSDirector/PDMR Shareholding
22nd Dec 20224:00 pmRNSDirector/PDMR Shareholding
13th Dec 202212:58 pmRNSDirector/PDMR Shareholding
11th Nov 202212:58 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSQ3 Trading Statement
31st Oct 202212:00 pmRNSExpiration and Results of Exchange Offers
13th Oct 202212:00 pmRNSDirector/PDMR Shareholding
10th Oct 20224:45 pmRNSDirector/PDMR Shareholding
10th Oct 20224:45 pmRNSDirector/PDMR Shareholding
29th Sep 20224:19 pmRNSExchange Offers for Certain Series of Notes
26th Sep 202212:45 pmRNSDirector/PDMR Shareholding
20th Sep 20227:00 amRNS2022 Half Year Results
13th Sep 20224:07 pmRNSChange to HY 2022 results date
1st Sep 202212:00 pmRNSTotal Voting Rights
19th Aug 202210:00 amRNSDirector Declaration
12th Aug 20227:00 amRNSStatement re Zantac
9th Aug 20222:30 pmRNSHolding(s) in Company - Replacement
4th Aug 202212:00 pmRNSHolding(s) in Company
3rd Aug 20223:00 pmRNSReduction of Capital Becomes Effective
3rd Aug 202212:33 pmRNSDirector/PDMR Shareholding
2nd Aug 20222:39 pmRNSDirector/PDMR Shareholding
1st Aug 20221:39 pmRNSTotal Voting Rights
29th Jul 20223:17 pmRNSDirector/PDMR Shareholding
28th Jul 20226:15 pmRNSDirector/PDMR Shareholding
28th Jul 20226:15 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSH1 Trading Update - Six Months Ended 30 June 2022
26th Jul 20226:00 pmRNSDirector/PDMR Shareholding
26th Jul 20225:40 pmRNSHolding(s) in Company
26th Jul 20225:35 pmRNSHolding(s) in Company
22nd Jul 202211:15 amRNSAppointment of Joint Corporate Brokers
21st Jul 20225:30 pmRNSDirector/PDMR Shareholding
21st Jul 20224:41 pmRNSSecond Price Monitoring Extn
21st Jul 20224:36 pmRNSPrice Monitoring Extension
20th Jul 20225:45 pmRNSDirector/PDMR Shareholding
20th Jul 20225:45 pmRNSDirector/PDMR Shareholding
20th Jul 20225:45 pmRNSDirector/PDMR Shareholding
19th Jul 202211:30 amRNSHolding(s) in Company
18th Jul 20226:01 pmRNSHolding(s) in Company
18th Jul 20226:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.